Recruiting
Atrial fibrillation+2
RecruitingStudy on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation
Registered drugNo placebo
Study on Early vs. Late Restart of Anticoagulation with Edoxaban, Apixaban, and Warfarin for Patients with Chronic Subdural Hematoma and Atrial Fibrillation
Registered drugNo placebo
- Disease:Atrial fibrillationNeurosurgery+1
- Substances:ApixabanLactose Monohydrate+2
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:Apixaban
- Sponsor:HUS-Yhtymae



